NOVARTIS

DC

Multinational Biopharmaceutical Company

Active 2007–2026. The register lists this client once for every firm that files on its behalf; all 34 of its records are shown together here.

Filings
803
Filed By
34
Reported In-House
$128,350,226
Reported By Firms
$26,914,000

These two figures are not added together. A client that lobbies for itself reports its own spending, while firms it retains report what they were paid. Disclosure rules ask the in-house figure to include those payments, but filings do not always do so, and a filing gives no way to tell. Each is shown as reported.

Filings

YearFirmPeriodAmountDoc
2026 TARPLIN, DOWNS & YOUNG, LLC 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$60,000
2026 NOVARTIS 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$840,000
2026 BGR GOVERNMENT AFFAIRS 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$60,000
2026 MONUMENT ADVOCACY 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$60,000
2026 TIBER CREEK HEALTH STRATEGIES, INC. 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report (No Activity)
$60,000
2026 BROWNSTEIN HYATT FARBER SCHRECK, LLP 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$90,000
2026 DLA PIPER LLP (US) 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$60,000
2026 CORCORAN & ASSOCIATES, INC. DBA CORCORAN PARTNERS 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$50,000
2026 TARPLIN, DOWNS & YOUNG, LLC 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
$60,000
2026 DLA PIPER LLP (US) 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
$60,000
Page 1 of 81  ·  803 filings Next
Filed By
Issue Areas

Bills Mentioned in Filings